Stock Market News Today Live Updates: GIFT Nifty Points To Gap-Up Open For Nifty, Sensex; Brent Crude Above $105 A Barrel

Morgan Stanley maintained an overweight rating on Lenskart with a target price of Rs 576, citing a Q4 beat and focus on sustaining growth. The brokerage said the company reiterated its 25% steady-state Ebitda margin target and expects FY27 store additions to be similar to FY26.

Jefferies maintained a buy rating and raised its target price to Rs 600 from Rs 575. The brokerage cited growth, margin gains and management’s focus on compounding growth.

Morgan Stanley maintained an equal-weight rating on Jubilant FoodWorks with a target price of Rs 486, citing a weak Q4 and margin pressure from LPG, labour and commodity costs.

Jefferies maintained a buy rating but cut its target price to Rs 600 from Rs 850, saying a pick-up in earnings growth is still awaited. Macquarie maintained an underperform rating with a target price of Rs 390, citing concerns over Jubilant’s ability to achieve 5–7% like-for-like growth over the next few quarters.

• Morgan Stanley maintained an overweight rating on Aditya Birla Capital with a target price of Rs 408 after the company raised Rs 4,000 crore through a preferential issue. The brokerage said post-money dilution will be 4%, while promoter shareholding will rise to 68.9%.
• Jefferies maintained a buy rating with a target price of Rs 425. The brokerage estimated the equity infusion to be 2% EPS accretive and 11% book value accretive, with a 3% accretion to SOTP valuation.

Jefferies maintained a buy rating on Grasim Industries and raised its target price to Rs 3,600 from Rs 3,440, citing a Q4 beat led by VSF performance and lower losses in new businesses.

Citi also maintained a buy rating and raised its target price to Rs 3,600 from Rs 3,450. The brokerage said Grasim’s paints market share crossed 10% and expects the stock to be driven by cement and paints, with support from VSF and chemicals.

Morgan Stanley said Birla Opus gained 90 basis points market share sequentially and crossed 10% paints market share in March 2026. It said competitive intensity remains high in the paints segment.

Morgan Stanley maintained an overweight rating on Apollo Hospitals with a target price of Rs 8,833, citing revenue growth, narrowing digital losses and a Q4 beat led by operating leverage.

Macquarie maintained an underperform rating with a target price of Rs 6,230. The brokerage said Apollo’s Q4 results were a modest beat and noted that the market may view the valuation of the Cloudnine transaction as underwhelming.

Morgan Stanley maintained an overweight rating on PI Industries with a target price of Rs 3,883.

The brokerage expects the company to move cautiously into FY27 and anticipates a return to positive revenue growth during the year, with improved prospects across agchem verticals. It said the pharma business may take two to three years to scale to twice its current revenue base, which it sees as a key level for margin improvement.

• OpenAI is working with Goldman Sachs and Morgan Stanley to draft its IPO prospectus, the Wall Street Journal reported.
• The company is seeking to be ready for an initial public offering as early as September, according to the report.

• Reliance Power said it will file an appeal challenging the confirmation of provisional attachment of assets worth Rs 407.6 crore.
• The company said the order will have no impact on its business operations, according to an exchange filing.

• SoftBank Group shares rose 19.8% on Thursday, adding about $35 billion to its market value, after Nvidia’s earnings signalled momentum in AI demand.
• The Japanese company has exposure to AI through its stake in Arm Holdings and investments in OpenAI. SoftBank shares had fallen for five straight sessions before Thursday’s rise.

• Hindalco Industries said the review timeline for the AluChem deal has been extended to July 2.
• The company said the review was affected by a partial US government shutdown. AluChem Cos is an arm of Hindalco, according to an exchange filing.

SEBI sent a show-cause notice to six Capital Group foreign portfolio investors, the Economic Times reported, citing a Feb. 2 notice from the regulator.

• Strides Pharma said the US FDA issued Form 483 with five observations for its Bengaluru facility.
• The regulator inspected the unit from May 12 to May 20, according to an exchange filing.

• Jubilant FoodWorks’ revenue rose 6.4% year-on-year to Rs 1,679.7 crore in the fourth quarter, while Ebitda rose 11.5% to Rs 345 crore. Net profit fell 13.9% to Rs 42.6 crore.
• The company reported 0.2% like-for-like growth, while dine-in and takeaway remained weak. Management reaffirmed its medium-term target of 5–7% like-for-like growth and 200-basis-point Ebitda margin expansion by FY28.
• Morgan Stanley maintained an equal-weight rating with a target price of Rs 486, Jefferies maintained a buy rating but cut its target price to Rs 600 from Rs 850, and Macquarie maintained an underperform rating with a target price of Rs 390.

• Apollo Hospitals reported growth across segments in Q4, led by higher hospital volumes, improved pricing and diagnostics.
• Hospital revenue rose 16% year-on-year, while Ebitda increased 14%. New hospitals recorded losses of Rs 41 crore, and excluding them, hospital Ebitda rose 20%. Occupancy improved to 68%, while ARPP rose 9%.
• HealthCo revenue grew 20%, with margins expanding as Apollo 24/7 costs reduced. AHLL revenue rose 24%, led by 52% growth in diagnostics. The company added four hospitals in FY26 and plans to expand total beds to about 13,100.

• Nifty futures rose 0.35% to 23,695 on Wednesday, trading at a 36-point premium.
• Maximum Call open interest was seen at the 24,500 strike, while maximum Put open interest was at the 22,500 strike for the May 19 expiry. The list of securities in the F&O ban period was not out yet.

WPIL (Q4, Consolidated YoY)

• Revenue down 10.6% to Rs 511 crore versus Rs 572 crore.

• Ebitda down 4.7% to Rs 76.2 crore versus Rs 79.9 crore.

• Margin at 14.9% versus 14.0%.

• Net profit up 2,208.6% to Rs 40.4 crore versus Rs 1.75 crore.

• Company recorded Rs 70.5 crore tax on discontinued operations in Q4 FY25.

Novelis (Q4, Consolidated YoY)

• Revenue up 4.4% to $4,787 million versus $4,587 million.

• Adjusted Ebitda down 3% to $459 million.

• Net loss at $84 million versus profit of $294 million.

• Oswego Hot Mill expected to resume operations in a few weeks.

PNC Infratech (Q4, Consolidated YoY)

• Revenue down 5.1% to Rs 1,617 crore versus Rs 1,704 crore.

• Ebitda down 23.5% to Rs 277 crore versus Rs 362 crore.

• Margin at 17.1% versus 21.3%.

• Net profit up 42.1% to Rs 108 crore versus Rs 76 crore.

• MD Chakresh Kumar Jain appointed as CFO.

Orkla India (Q4, Consolidated YoY)

• Revenue up 5% to Rs 626 crore versus Rs 596 crore.

• Ebitda up 2% to Rs 97.3 crore versus Rs 95.4 crore.

• Margin at 15.5% versus 16%.

• Net profit up 108.5% to Rs 73.4 crore versus Rs 35.2 crore.

Prince Pipes (Q4, YoY)

• Revenue up 18.1% to Rs 850 crore versus Rs 720 crore.

• Ebitda up 100.9% to Rs 109.7 crore versus Rs 54.6 crore.

• Margin at 12.9% versus 7.6%.

• Net profit up 131.8% to Rs 56.1 crore versus Rs 24.2 crore.

Bosch Home Comfort (Q4, YoY)

• Revenue up 3.5% to Rs 965.4 crore versus Rs 932.6 crore.

• Ebitda down 26.1% to Rs 67.8 crore versus Rs 91.7 crore.

• Margin at 7% versus 9.8%.

• Net profit down 27.1% to Rs 40.9 crore versus Rs 56.1 crore.

• Marcel Heese appointed Chairperson from July 1; Sanjay Sudhakaran reappointed as MD.

Zee Entertainment (Q4, Consolidated YoY)

• Revenue down 7.3% to Rs 2,025 crore versus Rs 2,184 crore.

• Ebitda loss at Rs 255 crore versus profit of Rs 298 crore.

• Net loss at Rs 102.4 crore versus profit of Rs 188.4 crore.

• Board declared dividend of Rs 2/share.

Trident (Q4, Consolidated YoY)

• Revenue down 12.4% to Rs 1,633 crore versus Rs 1,864 crore.

• Ebitda down 2.1% to Rs 242.2 crore versus Rs 247.4 crore.

• Margin at 14.8% versus 13.3%.

• Net profit down 23.5% to Rs 102 crore versus Rs 133.3 crore.

• Deepak Nanda reappointed as MD for three years.

• Board approved raising up to Rs 500 crore via NCDs.

Hatsun Agro (Q4, YoY)

• Revenue up 14.9% to Rs 2,578 crore versus Rs 2,243 crore.

• Ebitda up 4.8% to Rs 235.3 crore versus Rs 224.5 crore.

• Margin at 9.1% versus 10%.

• Net profit up 18.6% to Rs 51 crore versus Rs 43 crore.

• Board declared interim dividend of Rs 10/share.

Godawari Power (Q4, Consolidated YoY)

• Revenue up 9.7% to Rs 1,610 crore versus Rs 1,468 crore.

• Ebitda up 38.1% to Rs 439 crore versus Rs 318 crore.

• Margin at 27.3% versus 21.7%.

• Net profit up 26.7% to Rs 280 crore versus Rs 221 crore.

• Plans loan of up to Rs 150 crore to GERF and additional Rs 200 crore investment in Godawari New Energy.

Nephrocare Health (Q4, Consolidated YoY)

• Revenue up 21.5% to Rs 266 crore versus Rs 219 crore.

• Ebitda up 4.3% to Rs 53.6 crore versus Rs 51.4 crore.

• Margin at 20.2% versus 23.4%.

• Net profit up 22.1% to Rs 30.4 crore versus Rs 24.9 crore.

ASK Automotive (Q4, Consolidated YoY)

• Revenue up 35% to Rs 1,147 crore versus Rs 850 crore.

• Ebitda up 28.4% to Rs 133.3 crore versus Rs 103.8 crore.

• Margin at 11.6% versus 12.2%.

• Net profit up 24.1% to Rs 71.5 crore versus Rs 57.6 crore.

BPCL (Q4, QoQ)

• Revenue down 0.3% to Rs 1.18 lakh crore versus Rs 1.19 lakh crore.

• Ebitda down 13.8% to Rs 10,061 crore versus Rs 11,677 crore.

• Margin at 8.5% versus 9.8%.

• Net profit down 57.7% to Rs 3,191 crore versus Rs 7,545 crore.

• One-time loss stood at Rs 4,349 crore in Q4.

Dredging Corp (Q4, YoY)

• Revenue up 73.2% to Rs 478.2 crore versus Rs 276.1 crore.

• Ebitda up 334.7% to Rs 143 crore versus Rs 32.9 crore.

• Margin at 29.9% versus 11%.

• Net profit at Rs 86.9 crore versus loss of Rs 24.6 crore.

PTC India (Q4, Consolidated YoY)

• Revenue up 33.3% to Rs 3,898 crore versus Rs 2,924 crore.

• Ebitda down 6.9% to Rs 145 crore versus Rs 156 crore.

• Margin at 3.7% versus 5.3%.

• Net profit down 69.4% to Rs 105 crore versus Rs 343 crore.

• Board declared final dividend of Rs 5.50/share.

• Company to consider monetising stake in PTC India Financial Services.

Anthem Biosciences (Q4, Consolidated YoY)

• Revenue up 26.5% to Rs 611 crore versus Rs 483 crore.

• Ebitda up 36.9% to Rs 267 crore versus Rs 195 crore.

• Margin at 43.7% versus 40.4%.

• Net profit up 129.8% to Rs 189.8 crore versus Rs 82.6 crore.

• Board declared final dividend of Rs 2/share.

Mankind Pharma (Q4, Consolidated YoY)

• Revenue up 11.8% to Rs 3,443 crore versus Rs 3,079 crore.

• Ebitda up 36.2% to Rs 930 crore versus Rs 683 crore.

• Margin at 27% versus 22.2%.

• Net profit up 31.6% to Rs 554 crore versus Rs 421 crore.

• Satish Kumar Sharma appointed Whole-Time Director for five years.

• Company to invest additional Rs 500 crore in Mankind Medicare.

Karnataka Bank (Q4, YoY)

• NII up 8% to Rs 843 crore versus Rs 781 crore.

• Operating profit up 64% to Rs 615 crore versus Rs 375 crore.

• Net profit up 61.9% to Rs 408 crore versus Rs 252 crore.

• Gross NPA improved to 2.78% versus 3.32% QoQ.

• Net NPA improved to 0.98% versus 1.31% QoQ.

• Provisions down 4.8% to Rs 90.3 crore versus Rs 94.9 crore QoQ.

• Board declared final dividend of Rs 5/share.

Automotive Axles (Q4, YoY)

• Revenue up 18.6% to Rs 664 crore versus Rs 560 crore.

• Ebitda up 23.2% to Rs 77.1 crore versus Rs 62.6 crore.

• Margin at 11.6% versus 11.2%.

• Net profit up 17.4% to Rs 53.9 crore versus Rs 45.9 crore.

• Board declared final dividend of Rs 32/share; record date set as August 5.

Hindware Home Innovation (Q4, Consolidated YoY)

• Revenue down 5.2% to Rs 663 crore versus Rs 699 crore.

• Ebitda up 8.1% to Rs 44.2 crore versus Rs 40.9 crore.

• Margin at 6.7%.

• Net loss at Rs 19 crore versus loss of Rs 31 crore.

Viyash Scientific (Q4, Consolidated YoY)

• Revenue up 19.2% to Rs 920 crore versus Rs 772 crore.

• Ebitda up 62.8% to Rs 184 crore versus Rs 113 crore.

• Margin at 20% versus 14.6%.

• Net profit at Rs 52.1 crore versus loss of Rs 26.2 crore.

• One-time cost stood at Rs 7 crore in Q4.

CE Info Systems (Q4, Consolidated QoQ)

• Revenue up 54.7% to Rs 145 crore versus Rs 93.7 crore.

• EBIT up 197.9% to Rs 56.9 crore versus Rs 19.1 crore.

• EBIT margin at 39.2% versus 20.4%.

• Net profit up 170.2% to Rs 50.8 crore versus Rs 18.8 crore.

• Board declared final dividend of Rs 3.50/share.

Dynamatic Tech (Q4, Consolidated YoY)

• Revenue up 13.6% to Rs 433 crore versus Rs 381 crore.

• Ebitda up 28.2% to Rs 48.6 crore versus Rs 37.9 crore.

• Margin at 11.2% versus 10%.

• Net profit down 21.7% to Rs 12.6 crore versus Rs 16.1 crore.

• Board declared interim dividend of Rs 5/share.

Borosil (Q4, Consolidated YoY)

• Revenue up 5.2% to Rs 284 crore versus Rs 270 crore.

• Ebitda down 18.8% to Rs 30.2 crore versus Rs 37.2 crore.

• Margin at 10.6% versus 13.8%.

• Net profit down 4.5% to Rs 10.6 crore versus Rs 11.1 crore.

• Board approved raising up to Rs 250 crore via QIP and other routes.

Siyaram Silk Mills (Q4, Consolidated YoY)

• Revenue up 15.9% to Rs 853 crore versus Rs 736 crore.

• Ebitda up 23.4% to Rs 137 crore versus Rs 111 crore.

• Margin at 16% versus 15.1%.

• Net profit up 35.8% to Rs 97.8 crore versus Rs 72.04 crore.

• Board declared special dividend of Rs 4/share and final dividend of Rs 5/share.

Fine Organic (Q4, Consolidated YoY)

• Revenue up 3% to Rs 625 crore versus Rs 607 crore.

• Ebitda up 8.3% to Rs 130 crore versus Rs 120 crore.

• Margin at 20.8% versus 19.7%.

• Net profit up 21% to Rs 117.5 crore versus Rs 97.1 crore.

• Board declared final dividend of Rs 11/share.

• Company to acquire 80% stake in Oleofine Organics.

Stocks in focus include Aditya Birla Capital, which plans to issue shares worth up to Rs 4,000 crore on a preferential basis, and JSW Energy, whose board approved a QIP issue with a floor price of Rs 534.05 per share.

• Dalmia Bharat and Raymond will consider fundraising plans at upcoming board meetings.
• RVNL emerged as the lowest bidder for a Rs 164 crore East Coast Railway order, while Pace Digitek won a Rs 265 crore BSNL order.
• Hexaware Tech will acquire CPS through its UK arm for Rs 140 crore, while Vodafone Idea will buy a 26% stake in MTK Quantum Green Energy for Rs 4.3 crore.
• Akums Drugs’ subsidiaries received tax demands totalling Rs 134 crore from the Income Tax Department.

• Dynacons Systems & Solutions, Embassy Developments, Fineotex Chemical and Jain Resource Recycling have been shortlisted under the short-term ASM framework.
• Aequs, Frontier Springs, Rain Industries and Fujiyama Power Systems will be excluded from the ASM framework.

Jain Resource Recycling’s price band has been revised to 10% from 20%, according to trading tweak updates.

• Vikram Solar’s Nilam Chaudhary pledged 30 lakh shares, while Indiabulls’ Valerian Real Estate bought 17.41 lakh shares.
• Paisalo Digital’s promoter group entities created pledges on multiple shareholdings. Inox India’s Lata Madhusudan Rungta, part of the promoter group, sold 40,000 shares.

• SpaceX filed publicly for an initial public offering, with the listing targeted to raise as much as $75 billion.
• The filing showed a net loss of $4.28 billion on revenue of $4.69 billion for the first quarter. SpaceX also disclosed a super-voting share plan that would allow Elon Musk to retain control of the company.

• Nvidia forecast sales of about $91 billion for the quarter ending July, above the average Bloomberg estimate of $87 billion.
• For the quarter ended April 26, revenue rose 85% to $81.6 billion, while adjusted profit stood at $1.87 a share. The company also raised its quarterly dividend to 25 cents a share and announced $80 billion in stock repurchases. Its data centre unit reported revenue of $75.2 billion.

• Oil prices rose after a sharp fall on Wednesday as US President Donald Trump said Washington was in the “final stages” with Iran.
• Brent traded above $105 a barrel after dropping 5.6% in the previous session, while WTI was near $99. Traders are tracking talks that could lead to a restart of energy flows through the Strait of Hormuz.

The GIFT Nifty traded at 23,852, above the Nifty 50’s Wednesday close of 23,659, indicating a higher opening for Indian equities.

Asia-Pacific markets opened higher on Thursday after oil prices declined amid signs of progress in US-Iran negotiations.

• Japan’s Nikkei 225 rose over 3% after trade data showed exports grew 14.8% in April, led by semiconductor shipments
• South Korea’s Kospi gained 6%, while Samsung Electronics climbed more than 6% after workers averted a planned strike following wage talks
• SoftBank Group surged nearly 20% after Nvidia’s earnings boosted optimism around AI demand
• Australia’s S&P/ASX 200 advanced 1.66%, while Hong Kong Hang Seng futures traded above the previous close